Breaking News Instant updates and real-time market news.

TURN

180 Degree Capital

$1.92

(0.00%)

, TST

TheStreet

$5.78

(0.00%)

09:06
06/12/19
06/12
09:06
06/12/19
09:06

180 Degree Capital portfolio company TheStreet to be acquired by Maven

180 Degree Capital (TURN) notes that its portfolio company, TheStreet (TST) announced that it has entered into a definitive merger agreement with TheMaven (MVEN), by which a subsidiary of TheMaven will acquire all of the outstanding common shares of TST for $16.5M in cash. According to TST, in addition to a pro-rata portion of the Purchase Price, stockholders of TST will receive additional consideration in connection with the closing of the merger transaction consisting of, a special cash distribution equal to the cash held by TST immediately prior to the closing less any excluded liabilities as agreed to between the parties; and a contingent value right, or CVR, which will entitle each holder to receive a pro-rata portion of the expected release of funds from the outstanding escrow agreements entered into by TST in connection with the sale of each its RateWatch and BoardEx/TheDeal businesses. TST noted that its stockholders are expected to receive total cash consideration, including payments under the CVR, of $33M - $34.5M, or $6.19 - $6.47 per share. 180 directly owns 471,521 shares of TST. 180 is the investment manager of TheStreet SPV Series - a Series of 180 Degree Capital Management, LLC, that owns 350,000 shares of TST. 180 receives carried interest on profits generated on capital managed in TST SPV. TST further noted that the transaction is subject to the approval of a majority of the outstanding shares of common stock in TST under Delaware law and is expected to be submitted for stockholder approval and close in the third quarter of 2019.

TURN

180 Degree Capital

$1.92

(0.00%)

TST

TheStreet

$5.78

(0.00%)

MVEN

Maven

$0.00

(0.00%)

TURN 180 Degree Capital
$1.92

(0.00%)

TST TheStreet
$5.78

(0.00%)

11/15/18
LSCM
11/15/18
NO CHANGE
Target $3
LSCM
Buy
TheStreet deferred revenue accelerated in Q3, says Lake Street
Lake Street analyst Mark Argento says TheStreet posted "solid" Q3 results as deferred revenue started to accelerate. Strength in business-to-business, specifically BoardEx, along with premium business-to-consumer subscribers continued to drive increased deferred subscription revenue, Argento tells investors in a post-earnings research note. The analyst reiterates a Buy rating on the shares with a $3 price target.
12/06/18
RILY
12/06/18
NO CHANGE
Target $3
RILY
Buy
TheStreet trading below net cash after asset sale, says B. Riley FBR
TheStreet shares are trading below net cash following the sale of its institutional business units for $87.3M, B. Riley FBR analyst Kara Anderson tells investors in a research note. She reiterates a Buy rating on the name with a $3.00 price target.
04/04/19
LSCM
04/04/19
NO CHANGE
Target $3
LSCM
Buy
TheStreet distribution 'just right' in size, says Lake Street
TheStreet's $94.3M distribution, equating to $1.77 per share in cash, is "just right" in size, Lake Street analyst Mark Argento tells investors in a research note. The distribution leaves more than enough capital to run the remaining consumer business for the foreseeable future while the company continues to explore strategic alternatives, Argento tells investors in a research note. He believes the move is in the best interest of shareholders. The analyst keeps a Buy rating on TheStreet with a $3 price target.
05/15/19
NORL
05/15/19
NO CHANGE
Target $10
NORL
Outperform
TheStreet price target raised to $10 from $3 at Northland
Northland analyst Mike Grondahl raised his price target on the TheStreet to $10 from $3 after the company reported Q1 earnings, stating that while low margin ad revenue is still a headwind, the underlying metrics of its consumer business were "nicely improved." He keeps an Outperform rating on TheStreet shares.
MVEN Maven
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

PSNL

Personalis

$0.00

(0.00%)

10:59
06/20/19
06/20
10:59
06/20/19
10:59
Syndicate
Personalis indicated to open at $28, IPO priced at $17 »

Personalis (PSNL) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AGCO

Agco

$75.20

0.33 (0.44%)

10:57
06/20/19
06/20
10:57
06/20/19
10:57
Conference/Events
Agco management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

WORK

Slack Technologies

$0.00

(0.00%)

10:54
06/20/19
06/20
10:54
06/20/19
10:54
Syndicate
Breaking Syndicate news story on Slack Technologies »

Slack Technologies direct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

VanEck Vectors Gold Miners ETF

$24.79

0.82 (3.42%)

10:50
06/20/19
06/20
10:50
06/20/19
10:50
Options
Recent call buyer in Gold Miners ETF hit the mother lode on Fed stance »

Recent call buyer in Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$11.13

-0.39 (-3.39%)

10:45
06/20/19
06/20
10:45
06/20/19
10:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

10:45
06/20/19
06/20
10:45
06/20/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
06/20/19
06/20
10:45
06/20/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

TSN

Tyson Foods

$77.87

0.1 (0.13%)

10:45
06/20/19
06/20
10:45
06/20/19
10:45
Earnings
Tyson Foods sees adjusted EPS growth in 'high single digits' »

In analyst day slides,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AAPL

Apple

$198.90

1.03 (0.52%)

10:44
06/20/19
06/20
10:44
06/20/19
10:44
Hot Stocks
Apple, in letter to Lighthizer, urges U.S. not to impose additional tariffs »

Apple said in a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.16

0.11 (0.58%)

, EADSY

Airbus

$0.00

(0.00%)

10:43
06/20/19
06/20
10:43
06/20/19
10:43
Periodicals
JetBlue to order 13 A321XLR aircraft from Airbus, Reuters says »

JetBlue (JBLU) will order…

JBLU

JetBlue

$19.16

0.11 (0.58%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCEL

Atreca

$0.00

(0.00%)

10:40
06/20/19
06/20
10:40
06/20/19
10:40
Syndicate
Breaking Syndicate news story on Atreca »

Atreca opens at $19.90,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DPUKY

Domino's Pizza Group

$0.00

(0.00%)

10:38
06/20/19
06/20
10:38
06/20/19
10:38
Periodicals
Domino's Pizza Group in talks to replace CEO, Sky News reports »

Domino's Pizza Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$160.99

-1.56 (-0.96%)

10:35
06/20/19
06/20
10:35
06/20/19
10:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANIP

ANI Pharmaceuticals

$76.25

1.86 (2.50%)

10:33
06/20/19
06/20
10:33
06/20/19
10:33
Hot Stocks
ANI Pharmaceuticals announces FDA approval for Vancomycin supplement »

ANI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$5.25

0.14 (2.74%)

10:31
06/20/19
06/20
10:31
06/20/19
10:31
Hot Stocks
FDA says Aclaris ad makes false or misleading claims about Eskata »

The FDA sent a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
06/20/19
06/20
10:30
06/20/19
10:30
General news
EIA natural gas storage change for week ending June 14 »

Gas inventories 115 Bcf…

10:30
06/20/19
06/20
10:30
06/20/19
10:30
General news
Treasury Action: Treasuries remain richer on the day »

Treasury Action:…

GO

Grocery Outlet

$0.00

(0.00%)

10:28
06/20/19
06/20
10:28
06/20/19
10:28
Syndicate
Grocery Outlet indicated to open at $30, IPO priced at $22 »

Grocery Outlet (GO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:27
06/20/19
06/20
10:27
06/20/19
10:27
General news
Trump tweets 'Iran made a very big mistake' »

President Trump tweeted,…

BCEL

Atreca

$0.00

(0.00%)

10:25
06/20/19
06/20
10:25
06/20/19
10:25
Syndicate
Atreca indicated to open at $20.30, IPO priced at $17.00 »

Atreca (BCEL) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:25
06/20/19
06/20
10:25
06/20/19
10:25
Conference/Events
Jefferies technology analysts to hold an analyst/industry conference call »

Analysts, along with Alan…

CVS

CVS Health

$53.97

-0.92 (-1.68%)

10:25
06/20/19
06/20
10:25
06/20/19
10:25
Conference/Events
CVS Health participates in a conference call with Morgan Stanley »

Healthcare Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

VSTM

Verastem

$1.72

-0.18 (-9.47%)

10:21
06/20/19
06/20
10:21
06/20/19
10:21
Downgrade
Verastem rating change at BTIG »

Verastem downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$0.00

(0.00%)

10:20
06/20/19
06/20
10:20
06/20/19
10:20
Syndicate
Slack Technologies direct listing indicated to open at $30-$34 per share »

Slack Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$130.24

2.35 (1.84%)

10:20
06/20/19
06/20
10:20
06/20/19
10:20
Options
Gold ETF option volume 7x normal as spot jumps 2% »

Gold ETF option volume 7x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.